Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Ole Skouvig Pedersen

Showing results (1-10 of 12) with videos related to

Pageof 2
Sort By:
BMJ Case Reports|June 17, 2024
Tuberculosis immune reconstitution syndrome (TB-IRIS) followed by recurring lymphadenitis up to 8 years post-antituberculous treatmentOle Skouvig Pedersen, Trine Ørhøj Barkholt, Stine Horskær Madsen, et al.
International Journal of Infectious Diseases : IJID : Official Publication of the International Society for Infectious Diseases|May 8, 2024
The role of whole genome sequencing in identifying occupational tuberculosis among healthcare workers: two case reportsOle Skouvig Pedersen, Victor Naestholt Dahl, Søren Sperling, et al.
Clinical Microbiology and Infection : the Official Publication of the European Society of Clinical Microbiology and Infectious Diseases|January 10, 2025
Evaluating stratified T-SPOT.TB results for diagnostic accuracy in tuberculosis disease: a retrospective cohort study with sensitivities, specificities, and predictive valuesOle Skouvig Pedersen, Søren Sperling, Anders Koch, et al.
Ugeskrift for Laeger|March 6, 2024
Ole Skouvig Pedersen, Frauke Rudolf, Isik Somuncu Johansen, et al.
The Lancet Regional Health. Western Pacific|April 10, 2026
Dynamic, quantitative ESAT6-CFP10 skin test for tuberculosis risk prediction: a large-scale, multi-center, prospective cohort studyPeng Lu, Zhongqi Li, Bilin Tao, et al.
The Journal of Infection|June 25, 2023
Global treatment outcomes of extensively drug-resistant tuberculosis in adults: A systematic review and meta-analysisOle Skouvig Pedersen, Freja Breth Holmgaard, Mads Kristian Duborg Mikkelsen, et al.
The Lancet Regional Health. Europe|July 23, 2025
Treatment outcomes of extensively drug-resistant tuberculosis in Europe: a retrospective cohort studyYousra Kherabi, Ole Skouvig Pedersen, Christoph Lange, et al.
Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America|April 25, 2025
Effectiveness of the BPaL(M) Regimen for Drug-Resistant Tuberculosis in Ukraine under Programmatic ConditionsVictor Naestholt Dahl, Ole Skouvig Pedersen, Tetiana Butova, et al.
Clinical Microbiology and Infection : the Official Publication of the European Society of Clinical Microbiology and Infectious Diseases|December 8, 2023
Treatment outcomes and risk factors for an unsuccessful outcome among patients with highly drug-resistant tuberculosis in UkraineOle Skouvig Pedersen, Tetiana Butova, Valeriy Kapustnyk, et al.
The Lancet Regional Health. Europe|September 15, 2025
Sex differences in risk factors for unsuccessful tuberculosis treatment outcomes in Eastern Europe from 2020 to 2022: a multi-country retrospective cohort studyOle Skouvig Pedersen, Tetiana Butova, Valerii Miasoiedov, et al.
Pageof 2

Showing results (1-10 of 12) with videos related to

Sort By:
Pageof 2
BMJ Case Reports|June 17, 2024
Tuberculosis immune reconstitution syndrome (TB-IRIS) followed by recurring lymphadenitis up to 8 years post-antituberculous treatmentOle Skouvig Pedersen, Trine Ørhøj Barkholt, Stine Horskær Madsen, et al.
International Journal of Infectious Diseases : IJID : Official Publication of the International Society for Infectious Diseases|May 8, 2024
The role of whole genome sequencing in identifying occupational tuberculosis among healthcare workers: two case reportsOle Skouvig Pedersen, Victor Naestholt Dahl, Søren Sperling, et al.
Clinical Microbiology and Infection : the Official Publication of the European Society of Clinical Microbiology and Infectious Diseases|January 10, 2025
Evaluating stratified T-SPOT.TB results for diagnostic accuracy in tuberculosis disease: a retrospective cohort study with sensitivities, specificities, and predictive valuesOle Skouvig Pedersen, Søren Sperling, Anders Koch, et al.
Ugeskrift for Laeger|March 6, 2024
Ole Skouvig Pedersen, Frauke Rudolf, Isik Somuncu Johansen, et al.
The Lancet Regional Health. Western Pacific|April 10, 2026
Dynamic, quantitative ESAT6-CFP10 skin test for tuberculosis risk prediction: a large-scale, multi-center, prospective cohort studyPeng Lu, Zhongqi Li, Bilin Tao, et al.
The Journal of Infection|June 25, 2023
Global treatment outcomes of extensively drug-resistant tuberculosis in adults: A systematic review and meta-analysisOle Skouvig Pedersen, Freja Breth Holmgaard, Mads Kristian Duborg Mikkelsen, et al.
The Lancet Regional Health. Europe|July 23, 2025
Treatment outcomes of extensively drug-resistant tuberculosis in Europe: a retrospective cohort studyYousra Kherabi, Ole Skouvig Pedersen, Christoph Lange, et al.
Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America|April 25, 2025
Effectiveness of the BPaL(M) Regimen for Drug-Resistant Tuberculosis in Ukraine under Programmatic ConditionsVictor Naestholt Dahl, Ole Skouvig Pedersen, Tetiana Butova, et al.
Clinical Microbiology and Infection : the Official Publication of the European Society of Clinical Microbiology and Infectious Diseases|December 8, 2023
Treatment outcomes and risk factors for an unsuccessful outcome among patients with highly drug-resistant tuberculosis in UkraineOle Skouvig Pedersen, Tetiana Butova, Valeriy Kapustnyk, et al.
The Lancet Regional Health. Europe|September 15, 2025
Sex differences in risk factors for unsuccessful tuberculosis treatment outcomes in Eastern Europe from 2020 to 2022: a multi-country retrospective cohort studyOle Skouvig Pedersen, Tetiana Butova, Valerii Miasoiedov, et al.
Pageof 2